Searched for
MEDICINE MANUFACTURING UNIT
Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...- In 1897, a German chemist while trying to ease his father’s rheumatic pains accidently developed a drug still widely used as an over-the-counter medication around the world: How did Felix Hoffmann invented Aspirin?In 1897, a German chemist while trying to ease his father’s rheumatic pains accidentally developed a drug still widely used as an over-the-...
- In 1849, an Italian-born inventor developed an early device for voice communications but couldn't afford a full patent due to financial hardship, allowing Alexander Graham Bell to get it in 1876: How did Telettrofono changed the world?In 1849, an Italian-born inventor developed an early device for voice communications but couldn't afford a full patent due to financial har...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyThe ET Health Conclave 2026 celebrated healthcare professionals and institutions. Leaders shared insights on healthcare infrastructure and ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 20%It was after quite some time that market breadth, always a better indicator of underlying sentiment, was positive for a few trading session...
- Dr Reddy's Laboratories launches generic Sugammadex injection in the United StatesDr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...
- India pharma sector to miss 2030 sales target amid tariff and shipping woes, trade body saysIndia's pharmaceutical industry is expected to reach$80-90 billion by 2030, well below its earlier$130 billion target, as U.S. tariff uncer...
- In 2009, a Navy veteran's low-cost invention helped thousands get glasses in places without eye doctorsUSee Vision Kit: Retired US Navy and Marine Corps officer, Kevin White, has pioneered a vision testing system aimed at providing affordable...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThe price of crude oil is down again despite the escalating tensions in the Gulf region. That augurs well for markets. This does not mean t...
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...
- In 1889, one invention solved the biggest problem every snow sled had; a flexible piece of steelIn 1889, downhill sledding was a dangerous game. Sleds couldn't steer at all. Riders had to jam a boot into the snow to turn or stop. Quake...
- Levothyroxine recalled nationwide by FDA; Earlier studies claim over 20 million Americans are 'unnecessarily' taking this thyroid medicationThe FDA has recalled levothyroxine sodium nationwide due to potency standard concerns. This medication is used to treat hypothyroidism and ...
- Quote of the day by Charlie Munger: “The single most important thing is knowing where...” — Inspiring life lessons on self-awareness, humility, wisdom, lifelong learning, and why understanding your limits can become your greatest advantage from the legendary investor and Berkshire Hathaway vice chairmanToday's Quote of the Day by Charlie Munger: Charlie Munger’s quote, "The single most important thing, if you want to avoid a lot of stupid ...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
- Generic drugmaker Sandoz to engage with US after Trump tariff threatUS President Donald Trump threatened steep tariffs on generic drugmakers. He stated medicines must be manufactured locally or face signific...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
Load More
